alzheimers

Scientists have identified new ways lithium chloride may interact with Alzheimer’s disease mechanisms at the cellular level. A new study from the University of Eastern Finland (UEF) suggests lithium chloride may influence several cellular processes linked to Alzheimer’s disease. Alzheimer’s disease (AD) is the most common type of dementia. One of its key features is [...]

Scientists around the world have been searching for better ways to treat Alzheimer’s disease, a condition that slowly destroys memory and thinking ability. Millions of families are affected by the disease, and the number of cases is expected to rise as populations continue to age. Alzheimer’s disease is often linked to abnormal protein buildup in […] The post Scientists use the brain’s own cleani…

Alzheimer’s disease is one of the biggest health challenges facing the world today. It slowly damages memory, thinking, and daily functioning, often making it hard for people to recognize loved ones or care for themselves. Scientists have spent decades searching for treatments, but progress has been slow and many experimental drugs have failed. One of […] The post Scientists find how to reverse A…

A widely available amino acid may offer a new way to target Alzheimer’s disease before major damage occurs. Scientists in Japan say a common amino acid already sold as a dietary supplement may help slow key processes linked to Alzheimer’s disease. In a study published in Neurochemistry International, researchers found that arginine reduced the buildup [...]

The actor-writer Nancey Silvers and director David I. Strasser discuss the themes of the Lifetime film and the heavy responsibility of caring for a loved one with Alzheimer's.

Eating eggs might do more than just start your day—it could help protect your brain. Researchers found that people 65 and older who eat eggs regularly have a significantly lower risk of developing Alzheimer’s disease, with daily or near-daily consumption linked to up to a 27% reduction. Even modest egg intake showed benefits, suggesting that small dietary changes could make a meaningful differenc…

Consumption of eggs is associated with a lower risk of being diagnosed with Alzheimer's Disease for those 65 years and older, according to researchers at Loma Linda University Health.

Alzheimer’s Research UK says patients at risk of being left behind as lack of formal or accurate diagnoses closes door to trials People with Alzheimer’s disease are missing out on experimental treatments because they are not diagnosed early or accurately enough to be enrolled in clinical trials, a UK charity has said. Trials of Alzheimer’s drugs reached a record high this year, according to data …

Alzheimer’s disease is one of the most serious health challenges in the world today. It affects more than 55 million people, and that number is expected to grow quickly in the coming years. For a long time, scientists believed that Alzheimer’s begins in the brain, caused by the slow buildup of harmful proteins that damage […] The post Could Alzheimer’s start in the gut? appeared first on Knowridg…

Alzheimer’s disease is one of the most serious brain conditions in the world today. It slowly damages memory, thinking ability, and daily functioning. Many people know that Alzheimer’s is linked to a buildup of a sticky protein called amyloid-beta in the brain. This protein forms clumps, often called plaques, that interfere with how brain cells […] The post A hidden brain cleaning system may hold…

Researchers have identified a new potential weapon against Alzheimer’s: blocking a protein called PTP1B. In mice, this approach boosted memory and helped brain immune cells clear harmful plaque buildup. Since PTP1B is also linked to diabetes and obesity—both risk factors for Alzheimer’s—it could offer a broader treatment strategy.

The list of potential benefits of GLP-1 drugs is only getting longer, with a new...

Alzheimer’s disease is often linked with memory loss, but the earliest signs can be much more subtle. One of the first changes many people experience is a reduced ability to smell. This may seem like a small issue, but it can be an early signal that something is happening in the brain. For many years, […] The post Why smell loss happens first in Alzheimer’s disease appeared first on Knowridge Sci…

The brain changes associated with Alzheimer's usually lead to a severe loss of memory and...

Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults. A team of investigators at Mass General Brigham reports that a blood test measuring plasma phosphorylated tau 217 (pTau217), a biomarker linked to Alzheimer’s disease, can forecast changes [...]

For many years, scientists believed that a protein called amyloid beta was the main cause of Alzheimer’s disease. This protein builds up in the brain long before symptoms appear. Because of this, many treatments have focused on removing amyloid in the hope of slowing the disease. However, a new review of research suggests that this […] The post Why clearing amyloid may not help Alzheimer’s patien…

Alzheimer’s disease is one of the most feared illnesses in the world. It slowly damages memory, thinking, and daily functioning. For many years, scientists have focused on a protein in the brain called amyloid beta. People with Alzheimer’s often have high levels of this protein, which forms sticky clumps in the brain. Because of this, […] The post Do Alzheimer’s anti-amyloid drugs really work? ap…

For many years, Alzheimer’s disease has been one of the biggest challenges in medicine. It slowly damages memory, thinking, and daily life, affecting millions of older adults around the world. Scientists have spent decades searching for treatments that can slow or stop the disease, and for a time, a group of drugs targeting a substance […] The post Alzheimer’s ‘breakthrough’ drugs face doubts aft…

Despite reducing amyloid plaques, antibody treatments for Alzheimer's fail to improve cognition, highlighting critical gaps in current therapeutic approaches.

Building on its longstanding leadership in Alzheimer’s disease genetics and biomarkers, Washington University School of Medicine in St. Louis has launched the Caribbean Omics & Genomics for Alzheimer Study (CONGAS) with the support of a five-year, $12 million grant from the National Institute on Aging, part of the National Institutes of Health (NIH). The central […]